Microbix Biosystems (TSX:MBX) Additional Paid-In Capital : C$10.32 Mil(As of Mar. 2024)

View and export this data going back to 1992. Start your Free Trial

What is Microbix Biosystems Additional Paid-In Capital?

Microbix Biosystems's quarterly additional paid-in capital increased from Sep. 2023 (C$10.22 Mil) to Dec. 2023 (C$10.42 Mil) but then stayed the same from Dec. 2023 (C$10.42 Mil) to Mar. 2024 (C$10.32 Mil).

Microbix Biosystems's annual additional paid-in capital declined from Sep. 2021 (C$10.70 Mil) to Sep. 2022 (C$9.62 Mil) but then increased from Sep. 2022 (C$9.62 Mil) to Sep. 2023 (C$10.22 Mil).

Microbix Biosystems Additional Paid-In Capital Historical Data

The historical data trend for Microbix Biosystems's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Microbix Biosystems Additional Paid-In Capital Chart

Microbix Biosystems Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Additional Paid-In Capital

Get a 7-Day Free Trial

9.39

10.25

10.70

9.62

10.22

Microbix Biosystems Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial															9.89	10.18	10.22	10.42	10.32

Microbix Biosystems Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Microbix Biosystems Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Microbix Biosystems's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Microbix Biosystems (TSX:MBX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Microbix Biosystems Inc (TSX:MBX) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

MBXBF:USA

Address

265 Watline Avenue, Mississauga, ON, CAN, L4Z 1P3

Website

https://www.microbix.com

Microbix Biosystems Inc develops biological products and technologies. The company manufactures and develops cell culture-based biological products and technologies. It has developed and acquired two technologies; Kinlytic and LumiSort. The company's operating segment includes Antigen, QAPs DxTM and Other Includes Kinlytic. It generates maximum revenue from the Antigen QAPs segment. Geographically, it derives a majority of revenue from North America.

Executives

James Stuart Currie

Senior Officer

Microbix Biosystems (TSX:MBX) Headlines

No Headlines